UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
October 14, 2008
SCIVANTA MEDICAL CORPORATION
(Exact name of registrant as specified in charter)
Nevada | 000-27119 | 22-2436721 | |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | |
215 Morris Avenue, Spring Lake, New Jersey | 07762 | ||
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (732) 282-1620
___________________________________________
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Section 8 - Other Information
Item 8.01. Other Events.
On October 14, 2008, Scivanta Medical Corporation issued a press release providing an update on the development of the Hickey Cardiac Monitoring System. A copy of the press release is attached hereto as Exhibit 99.1.
Section 9 - Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(d) | Exhibits: | |
Exhibit | ||
Number | Description | |
99.1 | Press Release Re: Scivanta Medical Corporation Provides Update on the Development of the Hickey Cardiac Monitoring System |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SCIVANTA MEDICAL CORPORATION | |
(Registrant) | |
By: | /s/ David R. LaVance |
David R. LaVance | |
Chairman of the Board, President and | |
Chief Executive Officer |
Date: October 14, 2008
3
EXHIBIT INDEX
Exhibit | |
Number | Description |
99.1 | Press Release Re: Scivanta Medical Corporation Provides Update on the Development of the Hickey Cardiac Monitoring System |
4